Effect and Safety of Cinnamaldehyde on Immunosuppressed Mice with Invasive Pulmonary Candidiasis

Jie-hua DENG; Ji-hong LI; Yi-le ZHAO; Gang-sheng WANG

doi:10.1007/s11655-020-3075-x

Your Location：

Home >

Browse articles >

Effect and Safety of Cinnamaldehyde on Immunosuppressed Mice with Invasive Pulmonary Candidiasis

Original Article | Updated：2021-08-16

- Effect and Safety of Cinnamaldehyde on Immunosuppressed Mice with Invasive Pulmonary Candidiasis
- Chinese Journal of Integrative Medicine Vol. 27, Issue 4, Pages: 286-290(2021)
- Affiliations：
  
  1.Department of Dermatology, the Second Hospital of Hebei Medical University, Shijiazhuang (050000), China
  2.Clinical Lab, the Second Hospital of Hebei Medical University, Shijiazhuang (050000), China
  3.Department of Pharmacy, the Second Hospital of Hebei Medical University, Shijiazhuang(050000), China
  4.Department of Scientific Research, the Second Hospital of Hebei Medical University, Shijiazhuang(050000), China
- Author bio：
  
  Correspondence to: Prof. WANG Gang-sheng, E-mail:djh092@163.com
- Funds：
- DOI：10.1007/s11655-020-3075-x
  CLC：
- Published：01 April 2021，
  
  Published Online：15 May 2020，
  
  Accepted：30 March 2018
Scan for full text
Jie-hua DENG, Ji-hong LI, Yi-le ZHAO, et al. Effect and Safety of Cinnamaldehyde on Immunosuppressed Mice with Invasive Pulmonary Candidiasis. [J]. Chinese Journal of Integrative Medicine 27(4):286-290(2021)
DOI：

Jie-hua DENG, Ji-hong LI, Yi-le ZHAO, et al. Effect and Safety of Cinnamaldehyde on Immunosuppressed Mice with Invasive Pulmonary Candidiasis. [J]. Chinese Journal of Integrative Medicine 27(4):286-290(2021) DOI： 10.1007/s11655-020-3075-x.

摘要

Abstract

Objective:

To evaluate the effect and safety of cinnamaldehyde on immunosuppressed mice with invasive pulmonary candidiasis.

Methods:

An immunosuppressed BALB/c mouse model was established by intraperitoneal administration of cyclophosphamide (200 mg/kg) once daily for 2 days. The immunosuppressed mouse with invasive pulmonary candidiasis model was further established by nasal perfusion of

Candida albicans

suspension. In the cinnamaldehyde treatment group

immunosuppressed mice with invasive pulmonary candidiasis were orally given cinnamaldehyde 240 mg/(kg•d) for 14 consecutive days. Fluconazole and 0.9% saline were used as the positive and negative controls

respectively. The mice in the cinnamaldehyde safety evaluation group were orally administered cinnamaldehyde 480 mg/(kg•d) for 42 days to observe the safety of the drug. Microscopic identification

fungal culture

histopathological examination

and (1

3)-beta-D-glucans detection were conducted to analyze the effect of cinnamaldehyde on

C. albicans

Results:

The fungal clearance rate in the cinnamaldehyde treatment group was higher than that in the fluconazole control group (80.00% vs. 56.67%

0.05). The level of (1

3)-β-D-glucan in the cinnamaldehyde treatment group was lower than that in the fluconazole positive control group (1160.62±89.65 pg/mL vs. 4285.87±215.62 pg/mL

0.05). The survival rate of mice in the cinnamaldehyde safety evaluation group was 100%

and no significant pathological changes of kidney

lung and liver were observed.

Conclusions:

Cinnamaldehyde was effective and safe in treating immunosuppressed BALB/c mice with invasive pulmonary candidiasis. It would be a potentially novel drug for anti-candidiasis infection.

关键词

Keywords

cinnamaldehydeCandida albicansinvasive pulmonary infectionChinese medicinesafety

references

Balaguer MP, Lopez-Carballo G, Catala R, Gavara R, Hernandez-Munoz P. Antifungal properties of gliadin films incorporating cinnamaldehyde and application in active food packaging of bread and cheese spread foodstuffs. Int J Food Microbiol 2013;166:369-377.

Kocevski D, Du MY, Kan JQ, Jing CJ, Lačnin I, Pavlović H.Antifungal effect of Allium tuberosum, Cinnamomum cassia, and Pogostemon cablin essential oils and their components against population of aspergillus species. J Food Sci 2013;78:M731-M737.

Li HB, Shen QS, Zhou W, Mo HZ, Pan DD, Hu LB.Nanocapsular dispersion of cinnamaldehyde for enhanced inhibitory activity against aflatoxin production by Aspergillus flavus. Molecules 2015;20:6022-6032.

Sharma J, Gairola S, Sharma YP, Gaur RD. Ethnomedicinal plants used to treat skin diseases by Tharu community of district Udham Singh Nagar, Uttarakhand, India.Ethnopharmacology 2014;158:104-206.

Yang F, Ding S, Liu W, Liu J, Zhang W, Zhao Q, et al.Antifungal activity of 40 TCMs used individually and in combination for treatment of superficial fungal infections. J Ethnopharmacol 2015;163:88-93.

Masevhe NA, Mc Gaw LJ, Eloff JN. The traditional use of plants to manage candidiasis and related infections in Venda, South Africa. J Ethnopharmacol 2015;168:364-372.

Deng JH, Wang GS, Ma YH. Study on anti-candida effect of 32 Chinese herbal extracts. World Chin J Digestol (Chin) 2010;18:741-743.

Wang GS, Deng JH, Ma YH. Experiments on effects of three botanicals on bioactivity of Aspergillus niger. Chin Arch Tradit Chin Med (Chin) 2013;10:2273-2274.

Wang GS, Deng JH, Jiang SH. Chinese medicine extraction group and the object ofCandida, Aspergillus in vitro antibacterial test. Lishizhen Med Mater Med Res (Chin)2010;21:884-885.

Ma YH, Deng JH, Wang GS. Therapeutic effect of cinnamon oil in mice with pulmonary Candida albicans infection. World Chin J Digestol (Chin) 2009;17:1545-1547.

Chen HL, Gong LZ, Guo JW, Huang YZ, Chen XP, Zhao DF, et al. Establishment of invasive pulmonary aspergillosis model in mice. Chin J Exp Clin Infect Dis (Chin) 2013;3:9-12.

Li F, Cao B, Qu JX, Shen H, Liu ZJ, Wang P. Experimental study on animal model of invasive pulmonary aspergillosis in mice. Chin J Clin (Chin) 2015;9:107-110.

Wang GS, Deng JH, Ma YH. Mechanisms, clinically curative effects, and antifungal activities of cinnamon oil and pogostemon oil complex against three species of Candida. J Tradit Chin Med (Chin) 2012;32:19-24.

Naveed R, Hussain I, Tawab A, Tariq M, Rahman M, Hameed S, et al. Antimicrobial activity of the bioactive components of essential oils from Pakistani spices against Salmonella and other multi-drug resistant bacteria. BMC Complement AIlternat Med 2013;13:265-268.

Xing FG, Hua HJ, Selvaraj JN, Zhao YJ, Zhou L, Liu X, et al.Growth inhibition and morphological alterations of Fusarium verticillioides by cinnamon oil and cinnamaldehyde. Food Control (Chin) 2014;46:343-350.

Graybill JR, Najva LK, Montalbo EM, Barchiesi FJ, Luther MF, Rinaldi MG. Treatment of histoplasmosis with MK-991(L-743, 872). Antimicrob Agents Chemother 1998;42:151-153.

Jiang QF, Zhou YJ, Sheng CQ, Wang JZ. Research progress on antifungal agents acting on fungal cell walls.Chin Pharm J (Chin) 2003;38:410-413.

Xie XM, Zhang WP, Fu YY, Xu Y. Study on the mechanism of action of cinnamaldehyde and citral against Aspergillus.J Chin Tradit Herb Drugs (Chin) 2004;35:430-432.

Wang K, Xu Z, Wang WQ, Zhu YH, Cui ZF. Mechanism of cinnamaldehyde-specific inhibition of yeast cell wall synthesis. Food Ferment Industr (Chin) 2012;38:68-71.

Huang J, Meng S, Hong S, Lin X, Jin W, Dong C. IL-17C is required for lethal inflammation during systemic fungal infection. Cell Mol Immunol (Chin) 2016;13:474-483.

Karageorgopoulos DE, Qu JM, Korbila IP, Zhu YG, Vasileiou VA, Falagas ME. Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin Microbial Infect 2013;19:39-49.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Efficacy and Safety of Jianpi Jieyu Decoction for Patients with Mild-to-Moderate Depression of Xin (Heart)-Pi (Spleen) Deficiency Syndrome: A Multi-centre Randomized Controlled Study

Safety of Thread Embedding Acupuncture Therapy:A Systematic Review^*

Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini

Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models

Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway

Related Author

No data

Related Institution

Xiyuan Clinical Medical College, Beijing University of Chinese Medicine

Department of Encephalopathy, Xiyuan Hospital, China Academy of Chinese Medical Sciences

First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine

Institute of Clinical Pharmacology, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Department of Encephalopathy, Botou Traditional Chinese Medicine Hospital of Hebei Province

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰